| Name | Rite Aid Pharmacy 05352 |
|---|---|
| Organization Name | Thrifty Payless Inc |
| Location | 10860 Se Oak St, Milwaukie, Oregon 97222 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (503) 652-8058 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
BioNumerik Pharmaceuticals, Inc. today announced the treatment of the first patients in a global multi-center Phase III clinical trial of Tavocept (BNP7787) in patients with primary adenocarcinoma of the lung, the most common type of lung cancer. In previous studies, Tavocept demonstrated the potential to substantially increase overall and one year patient survival while concurrently preventing and reducing the incidence and severity of common chemotherapy side-effects as compared to other currently available treatments for advanced lung cancer.
Roche announced today that it is proposing to acquire all outstanding shares of Illumina, Inc. for $44.50 per share in cash, or an aggregate of approximately $5.7 billion on a fully diluted basis.
After hearing for months about serious access issues involving tests that diagnose COVID-19 based on swabs from the nose or throat, Americans are being inundated with reports about promising new tests that look for signs of infection in the blood.
Scientists have found a correlation between a disease involving chronic pain and alterations in the gut microbiome.
Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according to the results of two studies published in The Lancet.
› Verified 7 days ago
| NPI Number | 1326054636 |
| Organization Name | THRIFTY PAYLESS INC |
| Doing Business As | RITE AID PHARMACY 05352 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 10860 Southeast Oak Street, Milwaukie Marketplace, Milwaukie, OR 97222 |
| Phone Number | 503-652-8058 |
News Archive
BioNumerik Pharmaceuticals, Inc. today announced the treatment of the first patients in a global multi-center Phase III clinical trial of Tavocept (BNP7787) in patients with primary adenocarcinoma of the lung, the most common type of lung cancer. In previous studies, Tavocept demonstrated the potential to substantially increase overall and one year patient survival while concurrently preventing and reducing the incidence and severity of common chemotherapy side-effects as compared to other currently available treatments for advanced lung cancer.
Roche announced today that it is proposing to acquire all outstanding shares of Illumina, Inc. for $44.50 per share in cash, or an aggregate of approximately $5.7 billion on a fully diluted basis.
After hearing for months about serious access issues involving tests that diagnose COVID-19 based on swabs from the nose or throat, Americans are being inundated with reports about promising new tests that look for signs of infection in the blood.
Scientists have found a correlation between a disease involving chronic pain and alterations in the gut microbiome.
Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according to the results of two studies published in The Lancet.
› Verified 7 days ago
| NPI Number | 1356750343 |
| Organization Name | RITE AID CORPORATION |
| Type | Community/Retail Pharmacy |
| Address | 10860 Se Oak St, Milwaukie, OR 97222 |
| Phone Number | 503-652-8058 |
News Archive
BioNumerik Pharmaceuticals, Inc. today announced the treatment of the first patients in a global multi-center Phase III clinical trial of Tavocept (BNP7787) in patients with primary adenocarcinoma of the lung, the most common type of lung cancer. In previous studies, Tavocept demonstrated the potential to substantially increase overall and one year patient survival while concurrently preventing and reducing the incidence and severity of common chemotherapy side-effects as compared to other currently available treatments for advanced lung cancer.
Roche announced today that it is proposing to acquire all outstanding shares of Illumina, Inc. for $44.50 per share in cash, or an aggregate of approximately $5.7 billion on a fully diluted basis.
After hearing for months about serious access issues involving tests that diagnose COVID-19 based on swabs from the nose or throat, Americans are being inundated with reports about promising new tests that look for signs of infection in the blood.
Scientists have found a correlation between a disease involving chronic pain and alterations in the gut microbiome.
Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according to the results of two studies published in The Lancet.
› Verified 7 days ago
News Archive
BioNumerik Pharmaceuticals, Inc. today announced the treatment of the first patients in a global multi-center Phase III clinical trial of Tavocept (BNP7787) in patients with primary adenocarcinoma of the lung, the most common type of lung cancer. In previous studies, Tavocept demonstrated the potential to substantially increase overall and one year patient survival while concurrently preventing and reducing the incidence and severity of common chemotherapy side-effects as compared to other currently available treatments for advanced lung cancer.
Roche announced today that it is proposing to acquire all outstanding shares of Illumina, Inc. for $44.50 per share in cash, or an aggregate of approximately $5.7 billion on a fully diluted basis.
After hearing for months about serious access issues involving tests that diagnose COVID-19 based on swabs from the nose or throat, Americans are being inundated with reports about promising new tests that look for signs of infection in the blood.
Scientists have found a correlation between a disease involving chronic pain and alterations in the gut microbiome.
Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according to the results of two studies published in The Lancet.
› Verified 7 days ago
Bellevue Healthcare Ii Inc Portland Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3601 Se Concord Rd, Milwaukie, Oregon 97267 Phone: (503) 659-1270 | |
Eyehealth Northwest Type: Eyewear Supplier (Equipment, not the service) Location: 11086 Se Oak St, Milwaukie, Oregon 97222 Phone: (503) 344-5170 | |
Fred Meyer Pharmacy 240 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 14700 Se Mcloughlin Blvd, Milwaukie, Oregon 97267 Phone: (503) 652-4133 | |
Keen Mobility Company Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9510 Se Main St, Milwaukie, Oregon 97222 Phone: (866) 737-5866 | |
Northwest Primary Care Group Pc Type: Medicare Supplier Location: 10024 Se 32nd Ave, Milwaukie, Oregon 97222 Phone: (503) 659-4988 |